简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2014-04-17 13:55 ASCO, ESMO, EORTC, ESO, and UICC Continue Endorsing the WIN Symposium Series in 2014
2014-04-15 18:16 Irvine Scientific Announces Expansion of BalanCD™ Product Line to Serve Vaccine Market
2014-04-14 18:02 New Studies Show Health Risks from Wireless Tech: Warnings from the BioInitiative Working Group
2014-04-14 10:00 Real-World Patient Survey Data Shows Negative Impact of Nocturia
2014-04-10 13:49 Menicon Donations Help Tohoku Soccer Get Back on Pitch
2014-04-10 11:11 Quintiles’ First Quarter 2014 Earnings Call Scheduled for Thursday, May 1st
2014-04-09 13:50 Sun Pharma to Acquire Ranbaxy in a US$ 4 Billion Landmark Transaction
2014-04-09 10:03 CEO Roundtable on Cancer Launches the Project Data Sphere Initiative, A New Data Sharing and Analytic Platform for Cancer Patient Benefit
2014-04-08 16:58 Bioventus Releases New EXOGEN® and Performance Guarantee in Canada
2014-04-08 10:34 Cell Signaling Technology, Inc. Announces PD-L1 Antibody, Important to Cancer Immunotherapy Research
2014-04-02 17:43 CROMA-PHARMA announced the signing of a significant Distribution Agreement with Asia´s leading Producer of Botulinum Toxins and Anti-Aging Products
2014-04-02 10:51 Economic Studies Reveal Challenges, Opportunities in China’s Health Care System
2014-03-28 18:00 Quintiles Appoints Dr. Stella Blackburn to Lead Global Risk Management for Real-World & Late Phase Research
2014-03-28 14:05 Nature Genetics Founding Editor Kevin Davies Joins Pathway Genomics’ Scientific Advisory Board
2014-03-27 13:50 Quintiles Announces Exercise of the Underwriters’ Option to Purchase Additional Secondary Shares
2014-03-25 15:00 Otsuka Pharmaceutical's Samsca® Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
2014-03-25 14:58 Oral OTEZLA® (apremilast) Demonstrated Clinically Meaningful and Sustained Improvements in Skin, Nail and Scalp of Adult Patients with Moderate to Severe Plaque Psoriasis
2014-03-25 14:47 OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis
2014-03-19 14:20 Shiseido Focuses on Langerhans Cells to Strengthen Skin Immunity
2014-03-19 11:55 Quintiles Announces Pricing of Secondary Public Offering

Business Wire Weibo

Press Releases

Latest Releases